Skip to content

Comparison the effect of oral Gabapentin and oral ondansetron and oral Ginger to prevention nausea and vomiting after cesarean section by spinal anesthesia

Comparison the effect of oral Gabapentin and oral ondansetron and oral Ginger to prevention nausea and vomiting after cesarean section by spinal anesthesia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201401014686N10
Enrollment
208
Registered
2014-01-03
Start date
2013-12-24
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nausea and vomiting after cesarean section by spinal anesthesia. Other complications of anaesthesia during pregnancy

Interventions

Intervention 1: First group (52 person )capsule gabapentin 300mg. Intervention 2: Second group (52 person) receive capsule ondansetron 8 mg. Intervention 3: Third group (52 person) receive capsule gi
Treatment - Drugs
First group (52 person )capsule gabapentin 300mg.
Second group (52 person) receive capsule ondansetron 8 mg.
Third group (52 person) receive capsule ginger 1 g.
Fourth group (52 person ) receive capsule placebo.

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age18-45; candidate for elective cesarean section by spinal anesthesia. Exclusion criteria: Motion Sickness: sensitivity to Gabapentin and ondansetron and Ginger;trial more than 2 times for spinal anesthesia.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Nausea and vomiting. Timepoint: 1,2,4,6 hour after intervention. Method of measurement: quadruplicate score.

Secondary

MeasureTime frame
Drug side effect. Timepoint: 1,2,4,6 after intervention. Method of measurement: quadruplicate score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehri Jamilian

Arak University of Medical Sciences

mjamilian@arakmu.ac.ir+98 86 3278 0660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026